Drug Type Small molecule drug |
Synonyms IMIDAZOLYL ETHANAMIDE PENTANDIOIC ACID, Vitaglutam, MYELO 001 + [2] |
Target- |
Action inhibitors, stimulants |
Mechanism Apoptosis inhibitors, Granulocytes stimulants, Haematopoiesis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Russia (01 Jan 2009), |
Regulation- |
Molecular FormulaC10H15N3O3 |
InChIKeyKZIMLUFVKJLCCH-UHFFFAOYSA-N |
CAS Registry219694-63-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Virus Diseases | Russia | 17 Jul 2014 | |
Influenza, Human | Russia | - | 01 Jan 2009 |
Neutropenia | Russia | - | 01 Jan 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | Russia | 06 Oct 2021 | |
Acute respiratory infections | Phase 3 | Russia | 03 Oct 2010 | |
Common Cold | Phase 3 | Russia | 03 Oct 2010 | |
Common Cold | Phase 3 | Russia | 03 Oct 2010 | |
Viral respiratory infection | Phase 3 | Russia | 03 Oct 2010 | |
Bone marrow depression | Phase 2 | Germany | 01 Mar 2016 | |
Cervical Intraepithelial Neoplasia | Phase 2 | Germany | 01 Mar 2016 | |
Febrile Neutropenia | Phase 2 | Germany | 01 Mar 2016 | |
Invasive Mammary Carcinoma | Phase 2 | Germany | 01 Mar 2016 | |
Acute Radiation Syndrome | Preclinical | Germany | 18 Jul 2019 |
Phase 2 | - | rpwoylfcjy(zisrgctqav) = reduced joynhfzkvm (pdpvabctgt ) View more | - | 25 May 2020 | |||
(Control) | |||||||
Phase 2 | 130 | oqtjqttrer(cbiqqptzoy) = jclxqtabzo hrkjexrinc (dcdoykzopz, 12.6 - 14.5) View more | Positive | 31 May 2019 | |||
placebo | oqtjqttrer(cbiqqptzoy) = cpalwjuiej hrkjexrinc (dcdoykzopz, 13.0 - 14.9) View more |